Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neuropharmacology

• Publication date

  2001-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0028-3908(01)00088-0PMID 11543764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of selective serotonin reuptake inhibitors.

  2000cited by this paper
• Losartan and its metabolite E3174 modify cardiac delayed rectifier K(+) currents.

  2000cited by this paper
• Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells.

  2000cited by this paper
• Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells.

  2000cited by this paper
• Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine

  1999cited by this paper
• Contributions of Kv3 Channels to Neuronal Excitability

  1999cited by this paper
• Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells.

  1999cited by this paper
• Function of specific K(+) channels in sustained high-frequency firing of fast-spiking neocortical interneurons.

  1999cited by this paper
• Block by fluoxetine of volume‐regulated anion channels

  1999cited by this paper
• Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3.

  1999cited by this paper
• Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding

  1999cited by this paper
• Kv3.1-Kv3.2 channels underlie a high-voltage-activating component of the delayed rectifier K+ current in projecting neurons from the globus pallidus.

  1999cited by this paper
• Inhibition of neuronal Na+ channels by antidepressant drugs.

  1998cited by this paper
• Contribution of the Kv3.1 potassium channel to high‐frequency firing in mouse auditory neurones

  1998cited by this paper
• Effects of propafenone and 5‐hydroxy‐propafenone on hKv1.5 channels

  1998cited by this paper
• Effect of fluoxetine on a neuronal, voltage‐dependent potassium channel (Kv1.1)

  1997cited by this paper
• Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5

  1997cited by this paper
• Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac).

  1997cited by this paper
• Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.

  1997cited by this paper
• Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels.

  1997cited by this paper
• Modulation of ionic currents in isolated canine and human jejunal circular smooth muscle cells by fluoxetine.

  1996cited by this paper
• Inhibition by nystatin of Kv1.3 channels expressed in Chinese hamster ovary cells.

  1996cited by this paper
• The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin.

  1996cited by this paper
• Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels.

  1996cited by this paper
• Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats

  1995cited by this paper
• Electrophysiological and pharmacological characterization of a mammalian Shaw channel expressed in NIH 3T3 fibroblasts.

  1995cited by this paper
• Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication.

  1995cited by this paper
• Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror

  1995cited by this paper
• Effect of Prozac on whole cell ionic currents in lens and corneal epithelia.

  1995cited by this paper
• Anticonvulsant effect of fluoxetine in humans

  1995cited by this paper
• Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel.

  1995cited by this paper
• Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).

  1995cited by this paper
• Differential expression of Shaw-related K+ channels in the rat central nervous system

  1994cited by this paper
• In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain

  1994cited by this paper
• Localization of a highly conserved human potassium channel gene (NGK2-KV4; KCNC1) to chromosome 11p15.

  1993cited by this paper
• A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression

  1993cited by this paper
• Antiepileptic Drug Mechanisms of Action

  1993cited by this paper
• Human brain fluoxetine concentrations.

  1993cited by this paper
• Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart.

  1993cited by this paper
• Anticonvulsant Effect of Fluoxetine on Focally Evoked Limbic Motor Seizures in Rats

  1993cited by this paper
• Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.

  1992cited by this paper
• The Shaw-related potassium channel gene, Kv3.1, on human chromosome 11, encodes the type l K+ channel in T cells.

  1992cited by this paper
• Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain.

  1992cited by this paper
• Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation.

  1991cited by this paper
• Alternative splicing contributes to K+ channel diversity in the mammalian central nervous system.

  1991cited by this paper
• Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds.

  1990cited by this paper
• Serum Fluoxetine and Norfluoxetine Concentrations and Antidepressant Response

  1989cited by this paper
• Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection.

  1988cited by this paper
• The pharmacologic profile of fluoxetine.

  1985cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper
• Ionic Blockage of Sodium Channels in Nerve

  1973cited by this paper

• Voltage-gated potassium channels (Kv) in GtoPdb v.2025.3

  2025cites this paper
• Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy

  2025cites this paper
• Duloxetine-induced inhibition of voltage-gated K+ 3.1 (Kv3.1) channels and underlying electrophysiological mechanisms.

  2025cites this paper
• Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes

  2025cites this paper
• Fluoxetine Treatment in Epilepsy of Infancy with Migrating Focal Seizures Due to KCNT1 Variants: An Open Label Study

  2025cites this paper
• Voltage-gated potassium channels (Kv) in GtoPdb v.2025.4

  2025cites this paper
• Structure-Activity Relationship Analysis of Fluoxetine for Suppression of Inflammatory Cytokine Production.

  2024cites this paper
• Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy

  2024cites this paper
• Inhibition of Ionic Currents by Fluoxetine in Vestibular Calyces in Different Epithelial Loci

  2024cites this paper
• TREK-1 and TREK-2 Knockout Mice Are Not Resistant to Halothane or Isoflurane

  2023cites this paper
• A novel KCNC1 gain‐of‐function variant causing developmental and epileptic encephalopathy: “Precision medicine” approach with fluoxetine

  2023cites this paper
• Voltage-gated potassium channels (Kv) in GtoPdb v.2023.1

  2023cites this paper
• Establishment of ion channel and ABC transporter assays in 3D-cultured ReNcell VM on a 384-pillar plate for neurotoxicity potential.

  2022cites this paper
• Voltage-gated potassium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Antidepressants are modifiers of lipid bilayer properties

  2019cites this paper
• Benzenesulfonamides act as open-channel blockers on KV3.1 potassium channel

  2018cites this paper
• 4-Chloro-3-nitro-N-butylbenzenesulfonamide acts on KV3.1 channels by an open-channel blocker mechanism

  2017cites this paper
• Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel

  2017cites this paper
• Implication du canal potassium Kv3.1 dans la lipotoxicité du 7-cétocholestérol, 24S-hydroxycholestérol et de l’acide tétracosanoïque sur des cellules nerveuses 158N et BV-2 : Etude des relations entre Kv3.1, homéostasie potassique et métabolisme peroxysomal dans la maladie d’Alzheimer

  2017cites this paper
• Evidence of K+ homeostasis disruption in cellular dysfunction triggered by 7-ketocholesterol, 24S-hydroxycholesterol, and tetracosanoic acid (C24:0) in 158N murine oligodendrocytes.

  2017cites this paper
• Molecular docking simulations and GRID-independent molecular descriptor (GRIND) analysis to probe stereoselective interactions of CYP3A4 inhibitors

  2017cites this paper
• Kv3 Channels: Enablers of Rapid Firing, Neurotransmitter Release, and Neuronal Endurance.

  2017cites this paper
• Inhibitory effect of chronic oral treatment with fluoxetine on capsaicin-induced external carotid vasodilatation in anaesthetised dogs

  2015cites this paper
• Effects of fluoxetine on cloned Kv4.3 potassium channels.

  2013cites this paper
• Ion channels as therapeutic targets: a drug discovery perspective.

  2013cites this paper
• Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

  2013cites this paper
• Block of cloned Kv4.3 potassium channels by dapoxetine.

  2012cites this paper
• The antidepressant citalopram inhibits delayed rectifier outward K+ current in mouse cortical neurons

  2012cites this paper
• Selective serotonin reuptake inhibitors and tricyclic antidepressants : novel immunomodulating agents

  2012cites this paper
• Duloxetine blocks cloned Kv4.3 potassium channels.

  2012cites this paper
• Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells

  2012cites this paper
• Drug side effects on KIR2.1 and hERG cardiac channels

  2011cites this paper
• Cellular Correlates of Enhanced Anxiety Caused by Acute Treatment with the Selective Serotonin Reuptake Inhibitor Fluoxetine in Rats

  2011cites this paper
• Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Different Classes of Antidepressants

  2011cites this paper
• Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5

  2010cites this paper
• Effect of psoralen on the cloned Kv3.1 currents

  2009cites this paper
• The Role of Kv3.3 Voltage-Gated Potassium Channel Expression in Cerebellar Purkinje Cells in Motor Coordination

  2009cites this paper
• Fluoxetine as a Potential Pharmacotherapy for Methamphetamine Dependence

  2006cites this paper
• Monoaminergic‐based Pharmacotherapy for Depression

  2005cites this paper
• Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies.

  2005cites this paper
• Inhibition of the human two‐pore domain potassium channel, TREK‐1, by fluoxetine and its metabolite norfluoxetine

  2005cites this paper
• Block of Delayed-Rectifier Potassium Channels by Reduced Haloperidol and Related Compounds in Mouse Cortical Neurons

  2005cites this paper
• Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.

  2005cites this paper
• Investigation of a role for noradrenaline in the neurochemical and behavioural effects of an established and putative target for antianxiety/antidepressant drugs: a microdialysis and behavioural study in rats and NK1 receptor knockout mice.

  2005cites this paper
• Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Various Antidepressant Drugs

  2004cites this paper
• Fluoxetine inhibits A-type potassium currents in primary cultured rat hippocampal neurons.

  2004cites this paper
• Effects of norfluoxetine on the action potential and transmembrane ion currents in canine ventricular cardiomyocytes

  2004cites this paper
• Fluoxetine blocks cloned neuronal A-type K+ channels Kv1.4

  2003cites this paper
• Fluoxetine depresses glutamate exocytosis in the rat cerebrocortical nerve terminals (synaptosomes) via inhibition of P/Q‐type Ca2+ channels

  2003cites this paper
• Inhibition of G protein‐activated inwardly rectifying K+ channels by fluoxetine (Prozac)

  2003cites this paper
• Fluoxetine Increases GABAA Receptor Activity through a Novel Modulatory Site

  2003cites this paper
• Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells.

  2003cites this paper
• The neurobiology and control of anxious states.

  2003cites this paper
• Molecular recognition: Identifying compounds and their targets

  2001cites this paper
• Effects of rosiglitazone, an antidiabetic drug, on Kv3.1 channels

  1993cites this paper